-
Two more suspects including woman charged over Louvre heist
-
Arteta hails Arsenal's 'exceptional' first half as leaders sink Burnley
-
Two more suspects charged over Louvre heist
-
More than $2 mn in weapons seized in deadly Rio anti-drug raid: govt
-
Feinberg-Mngomezulu guides South Africa to big win over Japan
-
Sinner crushes Zverev to reach Paris Masters final, brink of No.1
-
Pollock shines as England eventually overpower Australia
-
Villarreal crush Rayo to move second, Atletico beat Sevilla
-
Sinner crushes Zverev to reach Paris Masters final, brink of No. 1
-
Pollock shines as England beat Australia in Autumn opener
-
Ukraine sends special forces to embattled eastern city
-
Arsenal cruise against Burnley as Man Utd held
-
Pollock shines as England beat Australia 25-7 in Autumn Nations Series
-
Gyokeres on target as leaders Arsenal beat Burnley
-
Woman charged over Louvre heist tears up in court
-
Diomande dazzles as Leipzig go two points behind Bayern
-
Auger-Aliassime downs Bublik to reach Paris Masters final
-
Villarreal crush Rayo to move second in La Liga
-
Female suspect, 38, charged in Louvre heist: AFP
-
US not sending any high-level officials to COP30
-
India captain Kaur sees World Cup final as possible turning point
-
'Not out of the woods': What now for Britain's ex-prince Andrew?
-
Tens of thousands of Serbians mark first anniversary of deadly train station collapse
-
Tanzania president wins 98% in election as opposition says hundreds killed
-
Vieira 'no longer' manager of troubled Genoa: club
-
Tanzania president wins 98% of votes after violence-marred polls
-
South Korea hosts Xi as Chinese leader rekindles fraught ties
-
England's batting exposed as New Zealand seal ODI series sweep
-
Funk legend turned painter George Clinton opens show in Paris
-
Traditional mass wedding held in Nigeria to ensure prosperity
-
Canada PM says Xi talks 'turning point', apologises to Trump
-
Iranian tech prodigies battle it out with robots
-
Maldives begins 'generational ban' on smoking
-
Explorers seek ancient Antarctica ice in climate change study
-
India's Iyer discharged from hospital after lacerated spleen
-
Serbia marks first anniversary of deadly train station collapse
-
Latin America weathered Trump tariffs better than feared: regional bank chief
-
Bangladesh dockers strike over foreign takeover of key port
-
Tanzania president wins election landslide after deadly protests
-
Sixers suffer first loss, Bulls stay perfect as NBA Cup opens
-
Dodgers, Blue Jays gear up for winner-take-all World Series game seven
-
Taiwan's new opposition leader against defence spending hike
-
China to exempt some Nexperia chips from export ban
-
Dodgers hold off Blue Jays 3-1 to force World Series game seven
-
Crowns, beauty, fried chicken: Korean culture meets diplomacy at APEC
-
Panama wins canal expansion arbitration against Spanish company
-
Myanmar fireworks festival goers shun politics for tradition
-
China to exempt some Nexperia orders from export ban
-
Sixers suffer first loss as NBA Cup begins
-
China's Xi to meet South Korean leader, capping APEC summit
US cancels $590 million contract with Moderna for bird flu shot
US President Donald Trump's administration on Wednesday canceled a $590 million contract with Moderna to develop an avian flu vaccine, the US biotech company said.
It marked the latest move against vaccines by Health Secretary Robert F. Kennedy Jr, who has spent decades promoting misinformation about immunization.
The contract, announced on January 17 -- three days before Trump took office -- was for an mRNA vaccine targeting the H5N1 influenza strain, which has been circulating in birds and cattle.
Experts have warned the virus could jump to humans and spark a pandemic.
American pharmaceutical and biotechnology company Moderna disclosed the news as it announced positive results from an early stage clinical trial of 300 people designed to test safety and immune response.
"While the termination of funding from HHS adds uncertainty, we are pleased by the robust immune response and safety profile observed in this interim analysis of the Phase 1/2 study of our H5 avian flu vaccine and we will explore alternative paths forward for the program," said CEO Stephane Bancel in a statement.
"These clinical data in pandemic influenza underscore the critical role mRNA technology has played as a countermeasure to emerging health threats."
The statement added Moderna would "explore alternatives" for funding the development and manufacturing of the vaccine.
Dr. Ashish Jha, a public health expert who served as former president Joe Biden's Covid-19 response coordinator, reacted with dismay.
"The attack on mRNA vaccines is beyond absurd," he posted on X. "It was President Trump's Operation Warp Speed that gave us mRNA vaccines."
H.Darwish--SF-PST